反应条件
1.1: 1,1,1,3,3,3-hexamethyl-disilazane; n-butyllithium / diethyl ether / 0.75 h / -78 °C / Inert atmosphere 1.2: -78 - 28 °C 2.1: hydrogenchloride; hydrazine hydrate / ethanol; water / 3 h / Reflux View Scheme
参考文献
ICOZEN THERAPEUTICS PVT. LTD.; RHIZEN PHARMACEUTICALS S.A.; MUTHUPPALANIAPPAN, Peyyappan; VISWANADHA, Srikant; MERIKAPUDI, Gayatri, Swaroop; VAKKALANKA, Swaroop, Kumar, V.S.
Patent: WO2011/42797 A1, 2011 ;